From Breakthrough to Blockbuster: The Business of Biotechnology

In a market dominated by Big Pharma, small biotech companies have transformed the creation of new medicines, creating nearly 40 percent more of the most crucial medical treatments — and doing so on a budget. How has this been possible? In From Breakthrough to Blockbuster: The Business of Biotechnology (Oxford University Press), Drakeman, Drakeman, and Oraiopoulos show how biotech companies have beaten the odds to invent novel medicines with unprecedented efficiency.

Paw in print

Image
PAW's March 2025 cover, featuring the headling "Uncovering Cancer" and close-up of part of a DNA strand swirling like a tornado.
The Latest Issue

March 2025

Screening for cancer with liquid biopsy; PetroTiger; Endowments targeted.